Class effects of statins in elderly patients with congestive heart failure: a population-based analysis.

[1]  L. Morrison,et al.  Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI). , 2008, American heart journal.

[2]  Christopher P Cannon,et al.  Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. , 2006, Journal of the American College of Cardiology.

[3]  Alan Miller,et al.  The effect of statins in heart failure: beyond its cholesterol-lowering effect. , 2006, Journal of cardiac failure.

[4]  T. Pickering,et al.  Statin use in heart failure: a cause for concern? , 2006, American heart journal.

[5]  R. Collins,et al.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.

[6]  Joanna M. Young,et al.  Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure. , 2005, Atherosclerosis.

[7]  C. Stefanadis,et al.  Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure. , 2005, Atherosclerosis.

[8]  J. Tu,et al.  Statin use and survival outcomes in elderly patients with heart failure. , 2005, Archives of internal medicine.

[9]  R. Wooffitt,et al.  Similarities and Differences , 2005 .

[10]  U. Laufs,et al.  Pleiotropic effects of statins. - Basic research and clinical perspectives -. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[11]  C. Tsioufis,et al.  Effects of atorvastatin on reactive hyperaemia and the thrombosis–fibrinolysis system in patients with heart failure , 2004, Heart.

[12]  A. Yıldırır,et al.  Non-lipid effects of statins: emerging new indications. , 2004, Current vascular pharmacology.

[13]  J. Liao.  Statin Therapy for Cardiac Hypertrophy and Heart Failure , 2004, Journal of Investigative Medicine.

[14]  C. Heeschen,et al.  Beneficial effects of statins in patients with non-ischemic heart failure , 2004, Zeitschrift für Kardiologie.

[15]  G. Fonarow,et al.  Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure. , 2003, Journal of the American College of Cardiology.

[16]  S. Anker,et al.  The relationship between cholesterol and survival in patients with chronic heart failure. , 2003, Journal of the American College of Cardiology.

[17]  Sonia S Anand.  Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. Law MR, Wald NJ, Rudnicka AR. BMJ 2003; 326: 1407-408. , 2003, Vascular medicine.

[18]  M. Hori,et al.  Short-Term Statin Therapy Improves Cardiac Function and Symptoms in Patients With Idiopathic Dilated Cardiomyopathy , 2003, Circulation.

[19]  N J Wald,et al.  Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis , 2003, BMJ : British Medical Journal.

[20]  Peter C Austin,et al.  A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. , 2002, American heart journal.

[21]  G. Fonarow,et al.  Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. , 2002, Journal of cardiac failure.

[22]  S. Anker,et al.  The endotoxin-lipoprotein hypothesis , 2000, The Lancet.

[23]  A R Levy,et al.  Coding accuracy of hospital discharge data for elderly survivors of myocardial infarction. , 1999, The Canadian journal of cardiology.

[24]  D. Hunninghake,et al.  Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study) , 1998, The American journal of cardiology.

[25]  O. Faergeman,et al.  The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease. , 1997, Journal of cardiac failure.

[26]  H. Lennernäs,et al.  Pharmacodynamics and Pharmacokinetics of the HMG-CoA Reductase Inhibitors , 1997, Clinical pharmacokinetics.